title: Increased angiopoietin2 expression is associated with endothelial apoptosis and blood-brain barrier breakdown.
abstract: Normal intracerebral and pial vessels show constitutive expression of angiopoietin (Ang) 1 in endothelium while weak Ang2 immunoreactivity is present in occasional vessels. In the early phase postinjury, blood-brain barrier (BBB) breakdown at the lesion site is associated with decreased endothelial Ang1 and increased Ang2 expression, raising the possibility that Ang2 may have a role in early BBB breakdown. In order to determine whether Ang2 can cause BBB breakdown, the effect of recombinant Ang2 on cerebrovascular permeability to horseradish peroxidase (HRP) was studied in normal rat cortex. As hypothesized, Ang2 produced significant BBB breakdown to HRP as compared with vehicle-injected control rats. Since Ang2 is reported to have proapoptotic activity, the possibility that Ang2 may be associated with endothelial apoptosis was investigated in the rat cortical cold injury model over a period of 6 h to 6 days postinjury. Perilesion and pial vessels showed evidence of endothelial apoptosis as demonstrated by active Caspase-3 localization and TUNEL staining. Dual labeling for Ang proteins and active Caspase-3 demonstrated endothelial colocalization of Ang2 with active caspase-3. These data suggest that following injury, Ang2 may play a role in BBB breakdown of perilesional vessels, and it may also be a factor in endothelial cell apoptosis that occurs at days 1 and 2 following the injury.
authors.affiliation: Toronto Western Research Institute and Department of Pathology, University Health Network, Toronto, Ontario, Canada. nag@uhnres.utoronto.ca
authors.forename: Sukriti
authors.initials: S
authors.lastname: Nag
authors.forename: Tripti
authors.initials: T
authors.lastname: Papneja
authors.forename: Roopa
authors.initials: R
authors.lastname: Venugopalan
authors.forename: Duncan J
authors.initials: DJ
authors.lastname: Stewart
mesh_terms: D042683:Angiopoietin-1 / Q000031:analogs & derivatives / Q000502:physiology; D042702:Angiopoietin-2 / Q000096:biosynthesis*; D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D001812:Blood-Brain Barrier / Q000473:pathology*; D001930:Brain Injuries / Q000378:metabolism / Q000473:pathology; D053148:Caspase 3; D020169:Caspases / Q000378:metabolism; D002540:Cerebral Cortex / Q000098:blood supply / Q000378:metabolism / Q000473:pathology; D004730:Endothelium, Vascular / Q000473:pathology*; D020287:In Situ Nick-End Labeling; D008297:Male; D009389:Neovascularization, Pathologic / Q000378:metabolism / Q000473:pathology; D051381:Rats; D011920:Rats, Inbred WF; D017208:Rats, Wistar
chemical_list: D042683:Angiopoietin-1; D042702:Angiopoietin-2; C467629:Angpt1 protein, rat; C505410:Casp3 protein, rat; D053148:Caspase 3; D020169:Caspases